December 10, 2021
EPS Corporation
News Release

Speech on the Promotion of DCT*1 at the Keidanren
The EPS Corporation (Head Office: Shinjuku-ku, Tokyo; Representative: Akira Sasa; hereinafter,“EPS”) made a speech entitled “Promotion of DCT” at a health-tech strategic meeting held by theJapan Business Federation (Keidanren; Head Office: Chiyoda-ku, Tokyo; Chairman: Masakazu
Tokura; hereinafter, “Keidanren”) on November 15, 2021.
The Keidanren is gathering new proposals for online healthcare in Japan. One important element of
this online healthcare is “DCT.” EPS provides the Keidanren information and exchanges ideas withroughly twenty different pharmaceutical companies and other Keidanren members.
EPS is also advancing Virtual Go as a system to consider ways to build frameworks for rolling out
new systems and tools used in virtual/online clinical trials as well as initiatives to support burdenfree operation of those systems and tools in the homes of patients. However, Japanese laws,regulations, and even related government notifications do not often clarify the standards for
implementing the new systems and tools used in virtual/online clinical trials. This is one reason thatis preventing broader adoption of virtual/online clinical trials. The Ministry of Health, Labour andWelfare is furthering its investigation into “the creation of guidance for conducting clinical trials
using online technologies.” EPS believes that the faster Japan can clarify its standards to conduct suchclinical trials, the sooner the country will see widespread use of virtual/online clinical trials.
Please refer to Keidanren Times Article No. 3524, “Promotion of Clinical Trials Free from Hospital
Visits” (December 2, 2021) for more information about the Keidanren (Japanese).
https://www.keidanren.or.jp/journal/times/2021/1209_07.html

EPS Virtual Go Framework
As a leading company in clinical trial operations, EPS is advancing Virtual Go as a means to promote
virtual/online clinical trials via its cultivated expertise on data science, its extensive experience andproven track record.

Virtual Go is a generic name for all EPS services used to promote virtual/online clinical trials.
Virtual Go always strives to satisfy two core ideas: “virtual/online clinical trials in which patients do
not have to visit medical institutions” and “virtual/online clinical trials in which CRAs*2 do not haveto visit medical institutions.” To do this, EPS handles everything from proposal to the operation andmanagement of various schemes to advance virtual/online clinical trials right for the trial design andtype of disease. This includes eConsent*3, online medical examinations, DDC*4, eCOA*5, use ofwearable devices, shipment of drugs for clinical trials, home-visit nursing, and specimen collection.

About EPS Corporation
EPS launched its business in 1991 as a CRO*6 to comprehensively support clinical studies with thefocus on clinical trials and PMS*7. The company proposes new models to satisfy customers’ needsby leveraging its data science expertise and digital technology cultivated through its extensive trackrecord. These proposals are founded in its Trial GATE concept, which acts as the gateway for all
promotion functions of clinical trials.
*1: DCT (Decentralized Clinical Tria)*5: eCOA (Electronic Clinical Outcome Assessment)*2: CRA (Clinical Research Associate)*6: CRO (Contract Research Organization)*3: eConsent (Electronic Consent)*7: PMS (Post Marketing Surveillance）*4: DDC (Direct Data Capture)Contact: EPS Corporation
Administration Headquarters, General Affairs Office
Manager of Public Relations
E-mail: koho@eps.co.jp